Intelgenx Technologies Corp IGXT:OTCQB

*Data is delayed | Exchange | USD
Last | 04/18/24 EDT
0.17UNCH (UNCH)
52 week range
0.09 - 0.22
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.17
  • 52 Week High0.22
  • 52 Week High Date06/23/23
  • 52 Week Low0.09
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap29.19M
  • Shares Out174.66M
  • 10 Day Average Volume98,497.3
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change23.08

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.17
  • 52 Week High0.22
  • 52 Week High Date06/23/23
  • 52 Week Low0.09
  • 52 Week Low Date10/31/23
  • Market Cap29.19M
  • Shares Out174.66M
  • 10 Day Average Volume98,497.3
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change23.08

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-2.99
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/15/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Intelgenx Technologies Corp

 

Profile

MORE
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ, VetaFilm and transdermal VevaDerm, allows for pharmaceutical products that address unmet...
Horst Zerbe Ph.D.
Chairman of the Board
Dwight Gorham
Chief Executive Officer
Andre Godin CPA
President, Chief Financial Officer
Address
6420 Abrams St
Saint-laurent, QC
H4S 1Y2
Canada